AQR CAPITAL MANAGEMENT LLC

Position in NVS — Novartis AG

CIK 1167557 Greenwich, CT

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,723,794

+$9,997,254 QoQ

Shares Held

233,871

+25.3% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,739,029,995 across 16 Drug Manufacturers - General names. NVS ranks #11 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	29,631,105	$1,797,126,513
2	MRK	Merck & Co., Inc.	8,628,486	$1,037,920,575
3	JNJ	Johnson & Johnson	3,543,181	$866,095,157
4	LLY	ELI LILLY & Co	855,420	$786,789,649
5	BIIB	Biogen Inc.	1,923,557	$352,645,701
6	PFE	Pfizer Inc	11,879,235	$333,568,912
7	ABBV	AbbVie Inc.	888,913	$193,329,684
8	GILD	Gilead Sciences, Inc.	1,164,803	$162,338,589

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,723,794	233,871	+25.3%	Shares	Other	2026-05-15
2025-12-31	$25,726,540	186,600	+37.2%	Shares	Other	2026-02-17
2025-09-30	$17,435,380	135,959	+84.9%	Shares	Other	2025-11-14
2025-06-30	$8,895,686	73,512	+225.7%	Shares	Other	2025-08-14
2025-03-31	$2,516,437	22,573	+102.8%	Shares	Other	2025-05-15
2024-12-31	$1,082,961	11,129	-33.0%	Shares	Other	2025-02-14
2024-09-30	$1,909,906	16,605	+71.2%	Shares	Other	2024-11-14
2024-06-30	$1,032,874	9,702	+257.7%	Shares	Defined	2024-08-14
2024-03-31	$262,331	2,712	—	Shares	Other	2024-05-15
No filing history on record for this holder in this stock.